Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
Status:
Completed
Trial end date:
2018-09-03
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the pharmacokinetics of posaconazole (POS) administered
intravenously (IV) or orally to immunocompromised pediatric participants.